Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin alpha 1 in Chronic Hepatitis C Non-Responders
NCT01178996Phase 3Completed
- Sponsor
- Sigma-Tau
- Start
- Dec 2004
- Primary completion
- May 2008
- Modality
- Peptides
- Countries
- 5
01
Overview
A Phase 3 trial of thymosin alpha 1 in hepatitis C (HCV), sponsored by Sigma-Tau. Started Dec 2004; status: completed.
02
Drugs
thymosin alpha 1
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01178996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178996.